Options
Chavanon, Mira‐Lynn
Loading...
Preferred name
Chavanon, Mira‐Lynn
Official Name
Chavanon, Mira‐Lynn
Alternative Name
Chavanon, M.-L.
Now showing 1 - 4 of 4
2019Journal Article [["dc.bibliographiccitation.firstpage","658"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","ESC Heart Failure"],["dc.bibliographiccitation.lastpage","666"],["dc.bibliographiccitation.volume","6"],["dc.contributor.author","Schertz, Anna"],["dc.contributor.author","Herbeck Belnap, Birgit"],["dc.contributor.author","Chavanon, Mira‐Lynn"],["dc.contributor.author","Edelmann, Frank"],["dc.contributor.author","Wachter, Rolf"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.date.accessioned","2020-12-10T14:06:10Z"],["dc.date.available","2020-12-10T14:06:10Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1002/ehf2.12436"],["dc.identifier.eissn","2055-5822"],["dc.identifier.issn","2055-5822"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16561"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69805"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.notes.intern","Merged from goescholar"],["dc.rights","CC BY-NC 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by-nc/4.0"],["dc.title","Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI2019Journal Article [["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","JBMR Plus"],["dc.bibliographiccitation.volume","4"],["dc.contributor.author","Wilde, Deborah"],["dc.contributor.author","Wilken, Lara"],["dc.contributor.author","Stamm, Bettina"],["dc.contributor.author","Blaschke, Martina"],["dc.contributor.author","Heppner, Christina"],["dc.contributor.author","Chavanon, Mira‐Lynn"],["dc.contributor.author","Leha, Andreas"],["dc.contributor.author","Herrmann‐Lingen, Christoph"],["dc.contributor.author","Siggelkow, Heide"],["dc.date.accessioned","2021-06-01T10:50:47Z"],["dc.date.available","2021-06-01T10:50:47Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1002/jbm4.10245"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/17136"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/86788"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.notes.intern","Merged from goescholar"],["dc.relation.eissn","2473-4039"],["dc.relation.issn","2473-4039"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","The HPQ—Development and First Administration of a Questionnaire for Hypoparathyroid Patients"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI2015Journal Article [["dc.bibliographiccitation.artnumber","e0136739"],["dc.bibliographiccitation.issue","8"],["dc.bibliographiccitation.journal","PLoS ONE"],["dc.bibliographiccitation.volume","10"],["dc.contributor.author","Meyer, Thomas"],["dc.contributor.author","Chavanon, Mira-Lynn"],["dc.contributor.author","Herrrmann-Lingen, Christoph"],["dc.contributor.author","Roggenthien, Maren"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Pieske, Burkert M."],["dc.contributor.author","Wachter, R. Rolf"],["dc.contributor.author","Edelmann, Frank T."],["dc.date.accessioned","2018-11-07T09:53:06Z"],["dc.date.available","2018-11-07T09:53:06Z"],["dc.date.issued","2015"],["dc.description.abstract","Background The role of endothelin-1 (ET-1) in the neurobiology of anxiety is unknown, therefore, we assessed in the observational multicenter DIAST-CHF study whether the C-terminal ET-1 precursor fragment (CT-proET-1) is linked to anxiety. Methods Plasma concentrations of CT-proET-1 were measured in a total of 1,410 patients presenting with cardiovascular risk factors (mean age 66.91 +/- 8.2 years, 49.3% males, mean left ventricular ejection fraction 60.0 +/- 8.2%) who had completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. Results Among the total study cohort (n = 1,410), there were 118 subjects (8.4%) with an HADS anxiety score above the cut-off level of 11 suggestive of clinically relevant anxiety. Plasma CT-proET-1 levels were significantly lower in the group of anxious patients as compared to non-anxious patients (p = 0.013). In regression models adjusted for sex, age, systolic blood pressure, and diameters of left atrium and ventricle, plasma CT-proET-1 was again linked to anxiety (Exp(beta) = 0.247, 95%-confidence interval [95%-CI] = 0.067-0.914, p = 0.036). Given the high prevalence of depressive disorders in anxious patients, we additionally included the HADS depression score as an independent variable in the models and found that CT-proET-1 remained a significant predictor of anxiety, independent of comorbid depression (Exp(beta) = 0.114, 95%-CI = 0.023-0.566, p = 0.008). Conclusions Our data from a population-based study in outpatients with cardiovascular risk factors revealed that circulating CT-proET-1 levels are negatively associated with anxiety. Further investigations are required to clarify the putative anxiolytic effect of ET-1 or its precursor molecules in humans and to decipher its mechanistic pathways."],["dc.description.sponsorship","Open-Access Publikationsfonds 2015"],["dc.identifier.doi","10.1371/journal.pone.0136739"],["dc.identifier.isi","000360435500031"],["dc.identifier.pmid","26322793"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/12085"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/36258"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Public Library Science"],["dc.relation.issn","1932-6203"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]Details DOI PMID PMC WOS2020-02Journal Article Research Paper [["dc.bibliographiccitation.firstpage","134"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","European Journal of Cardiovascular Nursing"],["dc.bibliographiccitation.lastpage","141"],["dc.bibliographiccitation.volume","19"],["dc.contributor.author","Bosselmann, Lena"],["dc.contributor.author","Fangauf, Stella V."],["dc.contributor.author","Herbeck Belnap, Birgit"],["dc.contributor.author","Chavanon, Mira-Lynn"],["dc.contributor.author","Nagel, Jonas"],["dc.contributor.author","Neitzel, Claudia"],["dc.contributor.author","Schertz, Anna"],["dc.contributor.author","Hummers, Eva"],["dc.contributor.author","Wachter, Rolf"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.date.accessioned","2020-12-10T18:38:33Z"],["dc.date.available","2020-12-10T18:38:33Z"],["dc.date.issued","2020-02"],["dc.description.abstract","Background: Risk factor control is essential in limiting the progression of coronary heart disease, but the necessary active patient involvement is often difficult to realise, especially in patients suffering psychosocial risk factors (e.g. distress). Blended collaborative care has been shown as an effective treatment addition, in which a (non-physician) care manager supports patients in implementing and sustaining lifestyle changes, follows-up on patients, and integrates care across providers, targeting both, somatic and psychosocial risk factors. Aims: The aim of this study was to test the feasibility, acceptance and effect of a six-month blended collaborative care intervention in Germany. Methods: For our randomised controlled pilot study with a crossover design we recruited coronary heart disease patients with ⩾1 insufficiently controlled cardiac risk factors and randomised them to either immediate blended collaborative care intervention (immediate intervention group, n=20) or waiting control (waiting control group, n=20). Results: Participation rate in the intervention phase was 67% (n=40), and participants reported high satisfaction (M=1.63, standard deviation=0.69; scale 1 (very high) to 5 (very low)). The number of risk factors decreased significantly from baseline to six months in the immediate intervention group (t(60)=3.07, p=0.003), but not in the waiting control group t(60)=−0.29, p=0.77). Similarly, at the end of their intervention following the six-month waiting period, the waiting control group also showed a significant reduction of risk factors (t(60)=3.88, p\\u0026lt;0.001). Conclusion: This study shows that blended collaborative care can be a feasible, accepted and effective addition to standard medical care in the secondary prevention of coronary heart disease in the German healthcare system."],["dc.description.sponsorship","deutsches zentrum für herz-kreislaufforschung https://doi.org/10.13039/100010447"],["dc.identifier.doi","10.1177/1474515119880062"],["dc.identifier.eissn","1873-1953"],["dc.identifier.issn","1474-5151"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/77362"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.publisher","SAGE Publications"],["dc.relation.eissn","1873-1953"],["dc.relation.issn","1474-5151"],["dc.relation.orgunit","Institut für Allgemeinmedizin"],["dc.title","Blended collaborative care in the secondary prevention of coronary heart disease improves risk factor control: Results of a randomised feasibility study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]Details DOI